Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers-Reference-Cited by-同舟云学术

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers

Published:2012-03-30 Issue:13 Volume:40 Page:6319-6337
ISSN:1362-4962
Container-title:Nucleic Acids Research
language:en
Short-container-title:

Author:

Thiel Kristina W.¹,Hernandez Luiza I.¹,Dassie Justin P.¹¹,Thiel William H.¹,Liu Xiuying¹,Stockdale Katie R.¹,Rothman Alissa M.¹,Hernandez Frank J.¹,McNamara James O.¹,Giangrande Paloma H.¹¹

Affiliation:

1. Department of Internal Medicine, 2Department of Molecular and Cellular Biology Program and 3Department of Radiation Oncology, University of Iowa, Iowa City, IA 52242, USA

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/40/13/6319/25343724/gks294.pdf

Reference114 articles.

1. Global patterns of cancer incidence and mortality rates and trends;Jemal;Cancer Epidemiol. Biomarkers Prev.,2010

2. Cancer statistics, 2010;Jemal;CA Cancer J. Clin.,2010

3. Declining death rates reflect progress against cancer;Jemal;PLoS One,2010

4. Temporal trends in breast cancer mortality by state and race;DeSantis;Cancer Causes Control,2008

5. Targeting the function of the HER2 oncogene in human cancer therapeutics;Moasser;Oncogene,2007

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart Nanobiomaterials for Gene Delivery in Localized Cancer Therapy: An Overview from Emerging Materials and Devices to Clinical Applications;Current Cancer Drug Targets;2024-04-19

2. Selection of internalizing RNA aptamers into human breast cancer cells derived from primary sites;Journal of Cellular Biochemistry;2024-02-19

3. Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims;Biosensors;2024-01-31

4. APTAMERS: NANOMATERIALS AS A POTENTIAL AGENT FOR ANTIVIRAL THERAPEUTIC DRUG DELIVERY DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW;International Journal of Applied Pharmaceutics;2024-01-07

5. Aptamer-based Theranostics in Oncology: Design Strategies and Limitations;BIO Integration;2024